Position in CRSP
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$447,918
-$45,908 QoQ
Shares Held
9,416
-0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Derivatives in CRSP
reported options exposure · as of Mar 31, 2026CallValue
$9,514
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Arkadios Wealth Advisors holds $12,704,540 across 13 Biotechnology names. CRSP ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,435 | $3,426,657 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
11,960 | $2,261,037 | |
| 3 | TYRA |
Tyra Biosciences, Inc.
|
47,567 | $1,821,816 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,684 | $1,645,052 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
19,622 | $1,268,169 | |
| 6 | MRNA |
Moderna, Inc.
|
17,857 | $907,135 | |
| 7 | EXEL |
Exelixis, Inc.
|
11,098 | $475,992 | |
| 8 | CRSP |
CRISPR Therapeutics AG
This page
|
9,416 | $447,918 |
All Filings in CRSP
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $447,918 | 9,416 | Shares | Sole | 2026-05-18 | |
| 2026-03-31 | $9,514 | 200 | Call | Sole | 2026-05-18 | |
| 2025-12-31 | $493,826 | 9,417 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $10,488 | 200 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $671,949 | 10,368 | Shares | Sole | 2025-10-29 | |
| 2025-09-30 | $12,962 | 200 | Call | Sole | 2025-10-29 | |
| 2025-06-30 | $516,313 | 10,615 | Shares | Sole | 2025-08-04 | |
| 2025-06-30 | $43,776 | 900 | Call | Sole | 2025-08-04 | |
| 2025-03-31 | $382,428 | 11,238 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $478,656 | 12,161 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $530,639 | 11,295 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $581,741 | 10,771 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $740,694 | 10,867 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $690,165 | 11,025 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $511,091 | 11,260 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $624,838 | 11,130 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $528,648 | 11,688 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $476,905 | 11,732 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $851,771 | 13,034 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $805,202 | 13,250 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $830,070 | 13,224 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $971,499 | 12,820 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $19,028 | 170 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $27,521 | 170 | Shares | Sole | 2021-07-28 | |
| 2020-12-31 | $5,205 | 34 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,672 | 20 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,469 | 20 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $848 | 20 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||